Assessment of the Safety and Efficacy of Edoxaban for the Treatment of Venous Thromboembolism Secondary to Active Malignancy

Nobuhiro Hara; Takamichi Miyamoto; Takamasa Iwai; Junji Yamaguchi; Sadahiro Hijikata; Keita Watanabe; Yuichiro Sagawa; Ryo Masuda; Ryoichi Miyazaki; Naoyuki Miwa; Masahiro Sekigawa; Tetsuo Yamaguchi; Yasutoshi Nagata; Toshihiro Nozato; Toru Obayashi

doi:10.3400/avd.oa.17-00054

この記事には本公開記事があります。本公開記事を参照してください。
引用する場合も本公開記事を引用してください。

Assessment of the Safety and Efficacy of Edoxaban for the Treatment of Venous Thromboembolism Secondary to Active Malignancy

Nobuhiro Hara , Takamichi Miyamoto, Takamasa Iwai, Junji Yamaguchi, Sadahiro Hijikata, Keita Watanabe, Yuichiro Sagawa, Ryo Masuda, Ryoichi Miyazaki, Naoyuki Miwa, Masahiro Sekigawa, Tetsuo Yamaguchi, Yasutoshi Nagata, Toshihiro Nozato, Toru Obayashi

著者情報

Nobuhiro Hara 責任著者
Department of Cardiology, Japanese Red Cross Musashino Hospital
Takamichi Miyamoto
Department of Cardiology, Japanese Red Cross Musashino Hospital
Takamasa Iwai
Department of Cardiology, Japanese Red Cross Musashino Hospital
Junji Yamaguchi
Department of Cardiology, Japanese Red Cross Musashino Hospital
Sadahiro Hijikata
Department of Cardiology, Japanese Red Cross Musashino Hospital
Keita Watanabe
Department of Cardiology, Japanese Red Cross Musashino Hospital
Yuichiro Sagawa
Department of Cardiology, Japanese Red Cross Musashino Hospital
Ryo Masuda
Department of Cardiology, Japanese Red Cross Musashino Hospital
Ryoichi Miyazaki
Department of Cardiology, Japanese Red Cross Musashino Hospital
Naoyuki Miwa
Department of Cardiology, Japanese Red Cross Musashino Hospital
Masahiro Sekigawa
Department of Cardiology, Japanese Red Cross Musashino Hospital
Tetsuo Yamaguchi
Department of Cardiology, Japanese Red Cross Musashino Hospital
Yasutoshi Nagata
Department of Cardiology, Japanese Red Cross Musashino Hospital
Toshihiro Nozato
Department of Cardiology, Japanese Red Cross Musashino Hospital
Toru Obayashi
Department of Cardiology, Japanese Red Cross Musashino Hospital
Department of Health Science, Gunma Paz College

キーワード: edoxaban, DOAC, venous thromboembolism, malignancy

ジャーナルフリー早期公開

論文ID: oa.17-00054

DOI https://doi.org/10.3400/avd.oa.17-00054

この記事には本公開記事があります。

The final version of this article is now available: Vol. 10 (2017), No. 4 pp. 407-410

詳細

抄録

Objective: To assess the safety and efficacy of edoxaban for the treatment of venous thromboembolism (VTE) secondary to active malignancy.

Materials and Methods: We enrolled 48 patients with newly diagnosed VTE secondary to active malignancy that was treated with oral edoxaban for 1 year between September 2014 and August 2015. We retrospectively examined the presence or absence of recurrent symptomatic VTE, VTE-related mortality, and bleeding events.

Results: No recurrent symptomatic VTE or VTE-related deaths were recorded, enabling efficient assessment. Treatment safety was determined based on the reports of bleeding. Bleeding was reported in two patients, with serious bleeding in one of them.

Conclusion: Edoxaban is safe and effective for the treatment of VTE secondary to active malignancy.

責任著者(Corresponding author)

J-STAGEへの登録はこちら（無料）